Bristol-Myers Squibb Company (BMY) vs Intuitive Surgical, Inc. (ISRG)
A side-by-side comparison of Bristol-Myers Squibb Company and Intuitive Surgical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
BMY
Bristol-Myers Squibb Company
$63.10HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
ISRG
Intuitive Surgical, Inc.
$353.10HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
Total return — BMY vs ISRG
growth of $100 · dividends reinvested · last 26yBMY +246.7%ISRG +17722.7%ISRG compounded faster
Log scale — wide-divergence pair
BMY ISRG
BMY vs ISRG: by the numbers
- •BMY is the larger company ($128.85B vs $124.74B market cap).
- •BMY trades at the lower trailing earnings multiple (17.87 vs 41.16 P/E), one valuation lens rather than an overall verdict.
- •ISRG converts more revenue to profit (28.45% vs 15.01% net margin).
- •ISRG grew revenue faster over the past five years (16.41% vs 2.52% CAGR).
- •BMY pays a dividend (3.93% yield), while ISRG has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BMY | ISRG |
|---|---|---|
| P/E ratio | 17.87 | 41.16 |
| Forward P/E | 10.02 | 33.60 |
| P/S ratio | 2.68 | 11.75 |
| P/B ratio | 6.48 | 7.14 |
| PEG ratio | 1.90 | 3.17 |
| EV / EBITDA | 10.48 | 30.00 |
| FCF yield | 9.17% | 2.48% |
Profitability
| Metric | BMY | ISRG |
|---|---|---|
| Gross margin | 68.75% | 66.68% |
| Operating margin | 25.67% | 31.28% |
| Net margin | 15.01% | 28.45% |
| ROE | 36.25% | 17.28% |
| ROIC | 13.90% | 13.71% |
Dividends
| Metric | BMY | ISRG |
|---|---|---|
| Dividend yield | 3.93% | N/A |
| Payout ratio | 72.25% | N/A |
Growth (annualized)
| Metric | BMY | ISRG |
|---|---|---|
| Revenue CAGR (5Y) | 2.52% | 16.41% |
| EPS CAGR (5Y) | 9.38% | 21.51% |
| FCF CAGR (5Y) | -2.50% | 14.17% |
| Total return CAGR (5Y) | 2.58% | 2.22% |
Frequently asked
- Which has the lower trailing P/E, BMY or ISRG?
- BMY has the lower trailing P/E: BMY trades at 17.87 and ISRG at 41.16. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BMY or ISRG?
- Over the past five years, ISRG grew revenue faster — BMY at a 2.52% CAGR versus ISRG at 16.41%.
- Does BMY or ISRG pay a bigger dividend?
- BMY pays a dividend (3.93% yield), while ISRG has no payments in the available dividend history.
- Is BMY or ISRG more profitable?
- ISRG runs the higher net margin — BMY at 15.01% versus ISRG at 28.45%.
- How have BMY and ISRG total returns compared?
- Over the past 10 years, BMY delivered 1.95% and ISRG delivered 16.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioIntuitive Surgical P/E ratioBristol-Myers Squibb dividend yieldIntuitive Surgical dividend yieldBristol-Myers Squibb ROEIntuitive Surgical ROEBristol-Myers Squibb operating marginIntuitive Surgical operating marginBristol-Myers Squibb revenue growthIntuitive Surgical revenue growthBristol-Myers Squibb free cash flowIntuitive Surgical free cash flow
Bristol-Myers Squibb & Intuitive Surgical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.